Date: 2013-04-06
Reference number: OPUSeJ 201304061946ASA
Links: to published article:http://www.cfp.ca/content/59/1/55.short
to cover page: http://www.opusej.org/library/family-practice-patients-use-of-acetylsalicylic-acid-for-cardiovascular-disease-prevention-cover/
Title: Family practice patients’ use of acetylsalicylic acid for cardiovascular disease prevention
Authors: Michael Kolber, Nadder Sharif, Raelene Marceau and Olga SzafranModerator: N/A
Overview: N/A
Addendum: none
Erratum: none
Bibliography: (alphabetical) N/A
References:
Ajani UA, Ford ES, Greenland KJ, Giles WH, Mokdad AH. Aspirin use among U.S. adults: Behavioral Risk Factor Surveillance System. Am J Prev Med 2006;30(1):74-7. http://www.ajpmonline.org/article/S0749-3797(05)00347-8/abstract
Pignone M, Anderson GK, Binns K, Tilson HH, Weisman SM. Aspirin use among adults aged 40 and older in the United States: results of a national survey. Am J Prev Med 2007;32(5):403-7. http://www.ajpmonline.org/article/S0749-3797(07)00018-9/abstract
Berger JS, Brown DL, Becker RC. Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. Am J Med 2008; 121(1):43-9. http://www.amjmed.com/article/S0002-9343(07)00985-0/abstract
Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324(7329):71-86. Erratum in: BMJ 2002;324 (7330):141. http://www.bmj.com/content/324/7329/71?ijkey=d3bc892543af00d9904c57b92a7414b92a883c6a&keytype2=tf_ipsecsha
Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006;295(3):306-13. Erratum in: JAMA 2006;295 (17):2002. http://jama.jamanetwork.com/article.aspx?articleid=202217
Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352(13):1293-304. Epub 2005 Mar 7. http://www.nejm.org/doi/full/10.1056/NEJMoa050613
Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373(9678):1849-60. http://www.ncbi.nlm.nih.gov/pubmed/15753114?dopt=Abstract
Wolff T, Miller T, Ko S. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2009; 150(6):405-10. http://www.ncbi.nlm.nih.gov/pubmed/19293073?dopt=Abstract
Sørensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000;95(9):2218-24. http://www.ncbi.nlm.nih.gov/pubmed/11007221?dopt=Abstract
De Berardis G, Sacco M, Strippoli GF, Pellegrini F, Graziano G, Tognoni G, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ 2009;339:b4531.DOI:. http://www.bmj.com/content/339/bmj.b4531.abstract?ijkey=7e756e8c9b74bc3d2743223062a64eac50efc54e&keytype2=tf_ipsecsha
Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A, et al. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care 2003;26(12):3264-72.http://care.diabetesjournals.org/content/26/12/3264.abstract?ijkey=5bd2e41c8aefe9c8907b8e9dfb5518f040a02375&keytype2=tf_ipsecsha
Walsh M, Spurling G. Aspirin in type 2 diabetes: is there any evidence base? BMJ 2008;337:a1902.DOI:. http://www.bmj.com/content/337/bmj.a1902.full?ijkey=f3f75c17f3946cd8387a1d373aa7029fce80fb3d&keytype2=tf_ipsecsha
Lip GY, Felmeden DC. Antiplatelet agents and anticoagulants for hypertension. Cochrane Database Syst Rev 2004;(3):003186. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003186.pub2/abstract
Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA 2008;300(18):2134-41. Epub 2008 Nov 9. http://jama.jamanetwork.com/article.aspx?articleid=182877
Statistics Canada [website]. 2006 Community profiles. Peace River, Alberta. Catalogue no. 92-591-XWE. Ottawa, ON: Statistics Canada; 2010. www12.statcan.gc.ca/census-recensement/2006/dp-pd/prof/92-591/details/page.cfm?Lang=E&Geo1=CSD&Code1=4819038&Geo2=PR&Code2=48&Data=Count&SearchText=peaceriver&SearchType=Begins&SearchPR=48&B1=All&Custom=
Centers for Disease Control and Prevention. 2003 Behavioral risk factor surveillance system state questionnaire. Atlanta, GA: Centers for Disease Control and Prevention; 2002. www.cdc.gov/brfss/questionnaires/pdf-ques/2003brfss.pdf
Statistics Canada [website]. Canada’s population estimates. Population by sex and age group. Ottawa, ON: Statistics Canada; 2010. www.statcan.gc.ca/daily-quotidien/100929/dq100929b-eng.htm
Friedmann PD, Brett AS, Mayo-Smith MF. Differences in generalists’ and cardiologists’ perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease. Ann Intern Med 1996;124(4):414-21. http://www.ncbi.nlm.nih.gov/pubmed/8554250?dopt=Abstract
Frijling BD, Lobo CM, Keus IM, Jenks KM, Akkermans RP, Hulscher ME, et al. Perceptions of cardiovascular risk among patients with hypertension or diabetes. Patient Educ Couns 2004;52(1):47-53. http://www.pec-journal.com/article/S0738-3991(02)00248-3/abstract
Steering Committee of the Physicians’ Health Study Research Group. Final report on the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med 1989;321(3):129-35. http://www.ncbi.nlm.nih.gov/pubmed/2664509?dopt=Abstract
Patrono C, Baigent C, Hirsh J, Roth G. American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008; 133(6 Suppl):199S-233S. http://journal.publications.chestnet.org/article.aspx?articleid=1085929
Tsuyuki RT, Koshman S, Pearson G. Guideline for management of modifiable risk factors in adults at high risk for cardiovascular events. Edmonton, AB: Toward Optimized Practice; 2009. www.topalbertadoctors.org/cpgs.php?sid=11&cpg_cats=37
Guidelines & Protocols Advisory Committee. Cardiovascular disease— primary prevention. Vancouver, BC: British Columbia Medical Association; 2008. www.bcguidelines.ca/pdf/cvd.pdf
Public Health Agency of Canada. Tracking heart disease and stroke in Canada. Ottawa, ON: Public Health Agency of Canada; 2009. www.phac-aspc.gc.ca/publicat/2009/cvd-avc/pdf/cvd-avs-2009-eng.pdf
Laine L. Review article: gastrointestinal bleeding with low-dose aspirin— what’s the risk? Aliment Pharmacol Ther 2006;24(6):897-908. http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2006.03077.x/abstract
Derry S, Loke YK. Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis. BMJ 2000;321(7270):1183-7. http://www.bmj.com/content/321/7270/1183?ijkey=99f07f8d829be8d9fd6f31f1c48c57d0010d3d72&keytype2=tf_ipsecsha
Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004;329(7456):15-9. http://www.bmj.com/content/329/7456/15.abstract?ijkey=57a277cb297694f0ed087b0e76ac36cc01addb5a&keytype2=tf_ipsecsha
Allan GM, Kolber MR. ASA in primary prevention: do the benefits outweigh risks? Edmonton, AB: Alberta College of Family Physicians; 2009. www.acfp.ca/docs10/2010-08-09%20ASA%20Primary%20Prevention.pdf
Kolber MR, Wong CWK. Acetylsalicylic acid (ASA) to prevent colorectal cancer? Edmonton, AB: Alberta College of Family Physicians; 2011. www.acfp.ca/docs11/TFP47ASAColorectalCancer.pdf
Brown LC, Johnson JA, Majumdar SR, Tsuyuki RT, McAlister FA. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ 2004;171(10):1189-92. http://www.cmaj.ca/content/171/10/1189.abstract?ijkey=8321ecc4275741e213235fa005d824a5fd47f9c3&keytype2=tf_ipsecsha
Alter DA, Khaykin Y, Austin PC, Tu JV, Hux JE. Processes and outcomes of care for diabetic acute myocardial infarction patients in Ontario: do physicians undertreat? Diabetes Care 2003;26(5):1427-34. http://care.diabetesjournals.org/content/26/5/1427.abstract?ijkey=2940e887f8a7522020df784cd3c6cae650984846&keytype2=tf_ipsecsha
Grimaldi-Bensouda L, Rossignol M, Aubrun E, El Kerri N, Benichou J, Abenhaim L, et al. Agreement between patients’ self-report and physicians’ prescriptions on cardiovascular drug exposure: the PGRx database experience. Pharmacoepidemiol Drug Saf 2010;19(6):591-5. Erratum in: Pharmacoepidemiol Drug Saf 2010;19 (11):1209. http://www.ncbi.nlm.nih.gov/pubmed/20535758?dopt=Abstract
Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004;57(10):1096-103. http://www.jclinepi.com/article/S0895-4356(04)00113-1/abstract
Citation: Kolber, M et al, 2013, “Family practice patients’ use of acetylsalicylic acid for cardiovascular disease prevention”, Canadian Family Physician 59:1, 55-61. http://www.cfp.ca/content/59/1/55.short
Academic citations forward: none
Other citations forward: none